AiBreath Nano Exhaled Breath Analysis System

A breath analysis system that measures 13C isotope levels in exhaled breath, used for diagnostic testing purposes.

A biomicro array (chip) analysis system for detection of respiratory pathogen IgM antibodies. This system utilizes protein chip technology for immunological testing of respiratory tract pathogens.

A biomicro array (chip) analysis system for detection of both IgG and IgM antibodies related to respiratory diseases. This diagnostic system utilizes protein chip methodology for comprehensive respiratory pathology assessment.

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

An advanced multi-molecular breath analysis system featuring variable flow rate measurements and AI olfactory diagnostics. The DA series (DA2123 and DA7349 models) measures multiple exhaled gases including NO, H2S, H2, CH4, CO, CO2, and O2 for comprehensive inflammation and microbiota assessment. It is designed for respiratory, digestive, allergy, and immunology departments for academic research and high-level clinical services, addressing conditions related to microbiota imbalance and inflammation-related diseases.

An advanced breath analysis device for multi-molecular, multi-parameter inflammation and bacterial microbiota testing. The DA series includes configurations such as DA2123 with variable flow rate multi-parameter testing and DA7349 with NO, H2S, H2, CH4, CO, CO2, and O2 for comprehensive inflammation and microbiota breath testing plus AI olfactory diagnosis. It is designed for respiratory, digestive, allergy, and immunology departments for academic research and clinical applications including allergic rhinitis, asthma, irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, and gut-lung, gut-heart, gut-liver, and gut-brain axis dysbiosis conditions.

A breath analysis device for multi-molecular, multi-site, multi-parameter testing of respiratory and digestive conditions with complications. The CA series includes inflammatory phenotyping breath testing with NO baseline plus CO and H2S optional configurations, supporting online standard, offline, and tidal breath modes. It features breath quality control with standard gas and self-calibration, and is applicable to respiratory, pediatric, otolaryngology, surgery, radiology, and health screening departments for conditions including asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, nasal polyps, radiation pneumonitis, and perioperative pulmonary complications.

A multi-molecular, multi-site, multi-parameter breath analysis system for detecting inflammation and related conditions. The CA series includes multiple configurations (CA3478, CA3138, CA4458) that measure various exhaled gases including NO, CO, H2S, CH4, CO2, and O2 in different combinations. It supports online and offline sampling modes with quality control features, and is designed for respiratory, pediatric, ENT, surgical, radiology, and physical examination departments to diagnose conditions such as asthma, COPD, interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, and perioperative pulmonary complications.

A range of diagnostic products based on breath analysis technology for various health conditions. The product line is designed for non-invasive disease screening and early detection.

A multi-molecular breath analysis system that detects NO, H2S, H2, CH4, CO, CO2, and O2 for simultaneous assessment of intestinal inflammation and microbiota status. It features olfactory AI and multimodal diagnostic capabilities. The device is designed for use in gastroenterology, pediatrics, physical examinations, and allergy departments, and is indicated for conditions including irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, Helicobacter pylori infection, functional dyspepsia, liver disease, and allergic rhinitis/asthma.

A breath analysis device designed for clinics, pharmacies, health check centers, nursing homes, and community settings using the same gas detection technology as hospital systems. The TM series performs FeNO/CaNO/FeCO/FnNO testing for respiratory chronic disease tiered diagnosis and heart-lung health screening, helping optimize drug selection and reduce acute exacerbations, emergency hospitalizations, and lung cancer risk.

A breath analysis system available in three configurations: CA3478 (NO+H2+CO2), CA3138 (NO+H2S+CO2), and CA4458 (NO+H2S+H2+CH4+CO2+O2) for combined assessment of inflammation and intestinal microbiota. The device is applicable in digestive and oral clinics, pediatrics, physical examinations, and allergy departments for diagnosis of conditions including irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, Helicobacter pylori infection, functional dyspepsia, liver disease, halitosis, and allergic rhinitis/asthma.